Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development

Reference

• Anklam E, Bahl MI, Ball R, Beger RD, Cohen J, Fitzpatrick S, et al. Emerging technologies and their impact on regulatory science. Experimental Biology and Medicine. 2022;247(1):1-75. doi: 10.1177/15353702211052280.
   Google Scholar
• Heikkinen I, Eskola S, Acha V, Morrison A, Walker C, Weil C, et al. Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective. Drug Discovery Today. 2023;28(5):103526. doi: 10.1016/j.drudis.2023.103526.
   Google Scholar
• Jensen ET, Rigdon J, Rezaei KA, Saaddine J, Lundeen EA, Dabelea D, et al. Prevalence, progression, and modifiable risk factors for diabetic retinopathy in youth and young adults with youth-onset type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care. 2023;46(6):1252-60. doi: 10.2337/dc22-2503.
   Google Scholar
• Tiwari S, Kaur P, Gupta D, Chaudhury S, Chaudhary M, Mittal A, et al. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2024;24(1):50-85. doi: 10.2174/1871530323666230522112758.
   Google Scholar
• Wolosowicz M, Prokopiuk S, Kaminski TW. Recent advances in the treatment of insulin resistance targeting molecular and metabolic pathways: fighting a losing battle? Medicina. 2022;58(4):472. doi: 10.3390/medicina58040472.
   Google Scholar
• Bano I, Butt UD, Mohsan SAH. New challenges in drug discovery. Novel Platforms for Drug Delivery Applications: Elsevier. 2023;619-43. doi: 10.1016/B978-0-323-91376-8.00021-5.
   Google Scholar
• Gayathiri E, Prakash P, Kumaravel P, Jayaprakash J, Ragunathan MG, Sankar S, et al. Computational approaches for modeling and structural design of biological systems: A comprehensive review. Progress in Biophysics and Molecular Biology. 2023. doi: 10.1016/j.pbiomolbio.2023.08.002.
   Google Scholar
• Torfi A, Shirvani RA, Keneshloo Y, Tavaf N, Fox EA. Natural language processing advancements by deep learning: A survey. arXiv preprint arXiv:200301200. 2020. doi: 10.48550/arXiv.2003.01200.
   Google Scholar
• Aliper A, Kudrin R, Polykovskiy D, Kamya P, Tutubalina E, Chen S, et al. Prediction of Clinical Trials Outcomes Based on Target Choice and Clinical Trial Design with Multi‐Modal Artificial Intelligence. Clinical Pharmacology & Therapeutics. 2023;114(5):972-80. doi: 10.1002/cpt.3008.
   Google Scholar
• Gruber A, Führer F, Menz S, Diedam H, Göller AH, Schneckener S. Prediction of human pharmacokinetics from chemical structure: combining mechanistic modeling with machine learning. Journal of Pharmaceutical Sciences. 2023. doi: 10.1016/j.xphs.2023.10.035.
   Google Scholar
• Wu W-T, Li Y-J, Feng A-Z, Li L, Huang T, Xu A-D, et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models. Military Medical Research. 2021;8:1-12. doi: 10.1186/s40779-021-00338-z.
   Google Scholar
• Yang S, Kar S. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artificial Intelligence Chemistry. 2023;100011. doi: 10.1016/j.aichem.2023.100011.
   Google Scholar
• Hossain MA, Pervin R. Current antidiabetic drugs: review of their efficacy and safety. Nutritional and therapeutic interventions for diabetes and metabolic syndrome. 2018;455-73. doi: 10.1016/B978-0-12-812019-4.00034-9.
   Google Scholar
• Perez-Riverol Y, Vera R, Mazola Y, Musacchio A. A parallel systematic-Monte Carlo algorithm for exploring conformational space. Current topics in medicinal chemistry. 2012;12(16):1790-96. doi: 10.2174/156802612803989237..
   Google Scholar
• Hawkins PC. Conformation generation: the state of the art. Journal of chemical information and modeling. 2017;57(8):1747-56. doi: 10.1021/acs.jcim.7b00221.
   Google Scholar
• Newman DJ, Phil D. Natural products and drug discovery. National Science Review. 2022:nwac206. doi: 10.1093/nsr/nwac206.
   Google Scholar
• Shah M, Bashir S, Jaan S, Nawaz H, Nishan U, Abbasi SW, et al. Computational analysis of plant-derived terpenes as α-glucosidase inhibitors for the discovery of therapeutic agents against type 2 diabetes mellitus. South African Journal of Botany. 2021;143:462-73. doi: 10.1016/j.sajb.2021.09.030.
   Google Scholar
• Rashid F, Ahmad M, Ashfaq UA, Al-Mutairi AA, Al-Hussain SA. Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1, 1-Dioxido-2H-Benzo [e][1, 2] thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent. Drug Design, Development and Therapy. 2022;4043-60. doi: 10.2147/DDDT.S379205.
   Google Scholar
• Ghasemlou A, Uskoković V, Sefidbakht Y. Exploration of potential inhibitors for SARS‐CoV‐2 Mpro considering its mutants via structure‐based drug design, molecular docking, MD simulations, MM/PBSA, and DFT calculations. Biotechnology and Applied Biochemistry. 2023;70(1):439-57. doi: 10.1002/bab.2369.
   Google Scholar
• Shirazi J, Jafari S, Ryde U, Irani M. Catalytic Reaction Mechanism of Glyoxalase II: A Quantum Mechanics/Molecular Mechanics Study. The Journal of Physical Chemistry B. 2023. doi: 10.1021/acs.jpcb.3c01495.
   Google Scholar
• Kiss M, Timári I, Barna T, Mészáros Z, Slámová K, Bojarová P, et al. 2-Acetamido-2-deoxy-d-glucono-1, 5-lactone Sulfonylhydrazones: Synthesis and Evaluation as Inhibitors of Human OGA and HexB Enzymes. International Journal of Molecular Sciences. 2022;23(3):1037. doi: 10.3390/ijms23031037.
   Google Scholar
• Kulkarni PU, Shah H, Vyas VK. Hybrid Quantum Mechanics/Molecular Mechanics (QM/MM) Simulation: A Tool for Structure-Based Drug Design and Discovery. Mini Reviews in Medicinal Chemistry. 2022;22(8):1096-107. doi: 10.2174/1389557521666211007115250.
   Google Scholar
• Bai Q, Liu S, Tian Y, Xu T, Banegas‐Luna AJ, Pérez‐Sánchez H, et al. Application advances of deep learning methods for de novo drug design and molecular dynamics simulation. Wiley Interdisciplinary Reviews: Computational Molecular Science. 2022;12(3):e1581. doi: 10.1002/wcms.1581.
   Google Scholar
• Choudhury C, Murugan NA, Priyakumar UD. Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods. Drug Discovery Today. 2022;27(7):1847-61. doi: 10.1016/j.drudis.2022.03.006.
   Google Scholar
• Batool M, Ahmad B, Choi S. A structure-based drug discovery paradigm. International journal of molecular sciences. 2019;20(11):2783. doi: 10.3390/ijms20112783.
   Google Scholar
• Qi J-h, Chen P-y, Cai D-y, Wang Y, Wei Y-l, He S-p, et al. Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches. Frontiers in Endocrinology. 2023;13:1096655. doi: 10.3389/fendo.2022.1096655.
   Google Scholar
• Bhimanwar RS, Lokhande KB, Shrivastava A, Singh A, Chitlange SS, Mittal A. Identification of potential drug candidates as TGR5 agonist to combat type II diabetes using in silico docking and molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics. 2023;1-18. doi: 10.1080/07391102.2023.2173654.
   Google Scholar
• Wang L, Ding J, Pan L, Cao D, Jiang H, Ding X. Quantum chemical descriptors in quantitative structure–activity relationship models and their applications. Chemometrics and Intelligent Laboratory Systems. 2021;217:104384. doi: 10.1016/j.chemolab.2021.104384.
   Google Scholar
• Ragno R. www. 3d-qsar. com: a web portal that brings 3-D QSAR to all electronic devices—the Py-CoMFA web application as tool to build models from pre-aligned datasets. Journal of computer-aided molecular design. 2019;33:855-64. doi: 10.1007/s10822-019-00231-x.
   Google Scholar
• Cabezas D, Mellado G, Espinoza N, Gárate JA, Morales C, Castro-Alvarez A, et al. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies. Journal of Biomolecular Structure and Dynamics. 2023;1-10. doi: 10.1080/07391102.2023.2172457.
   Google Scholar
• Liu Y, Wang R, Ren C, Pan Y, Li J, Zhao X, et al. Two myricetin-derived flavonols from Morella rubra leaves as potent α-glucosidase inhibitors and structure-activity relationship study by computational chemistry. Oxidative Medicine and Cellular Longevity. 2022;2022. doi: 10.1155/2022/9012943.
   Google Scholar
• Choudhury C, Narahari Sastry G. Pharmacophore modelling and screening: concepts, recent developments and applications in rational drug design. Structural bioinformatics: applications in preclinical drug discovery process. 2019;25-53. doi: 10.1007/978-3-030-05282-9_2.
   Google Scholar
• Singh R, Rao HK, Singh TG. Comparison of safety and efficacy of pregabalin, duloxetine and their combination with epalrestat in diabetic neuropathy: a prospective, double-blind, randomized, controlled Trial. Journal of Applied Pharmaceutical Science. 2021;11(1):071-79. doi: 10.7324/JAPS.2021.11s108.
   Google Scholar
• Saeed M, Tasleem M, Shoib A, Kausar MA, Sulieman AME, Alabdallah NM, et al. Identification of putative plant-based ALR-2 inhibitors to treat diabetic peripheral neuropathy. Current Issues in Molecular Biology. 2022;44(7):2825-41. doi: 10.3390/cimb44070194.
   Google Scholar
• Nayarisseri A, Khandelwal R, Tanwar P, Madhavi M, Sharma D, Thakur G, et al. Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery. Current drug targets. 2021;22(6):631-55. doi: 10.2174/1389450122999210104205732.
   Google Scholar
• Watson SI, Pan Y. Evaluation of combinatorial optimisation algorithms for c-optimal experimental designs with correlated observations. Statistics and Computing. 2023;33(5):112. doi: 10.1007/s11222-023-10280-w.
   Google Scholar
• Zhang Y, Jin Z. Comprehensive learning Jaya algorithm for engineering design optimization problems. Journal of Intelligent Manufacturing. 2022;1-25. doi: 10.1007/s10845-020-01723-6.
   Google Scholar
• Greenhill S, Rana S, Gupta S, Vellanki P, Venkatesh S. Bayesian optimization for adaptive experimental design: A review. IEEE access. 2020;8:13937-48. doi: 10.1109/ACCESS.2020.2966228.
   Google Scholar
• Shi Y, Prieto PL, Zepel T, Grunert S, Hein JE. Automated experimentation powers data science in chemistry. Accounts of Chemical Research. 2021;54(3):546-55. doi: 10.1021/acs.accounts.0c00736.
   Google Scholar
• Churcher A, Ullah R, Ahmad J, Masood F, Gogate M, Alqahtani F, et al. An experimental analysis of attack classification using machine learning in IoT networks. Sensors. 2021;21(2):446. doi: 10.3390/s21020446.
   Google Scholar
• Lee CY, Chen Y-PP. Prediction of drug adverse events using deep learning in pharmaceutical discovery. Briefings in Bioinformatics. 2021;22(2):1884-901. doi: 10.1093/bib/bbaa040.
   Google Scholar
• Lee SJ, Bae SH, Jeon S, Ji HY, Han S. Combined translational pharmacometrics approach to support the design and conduct of the first‐in‐human study of DWP16001. British Journal of Clinical Pharmacology. 2023. doi: 10.1111/bcp.15891.
   Google Scholar
• Stalidzans E, Zanin M, Tieri P, Castiglione F, Polster A, Scheiner S, et al. Mechanistic modeling and multiscale applications for precision medicine: theory and practice. Network and systems medicine. 2020;3(1):36-56. doi: 10.1089/nsm.2020.0002.
   Google Scholar
• Yoon S, Guk J, Lee S-G, Chae D, Kim J-H, Park K. Model-informed precision dosing in vancomycin treatment. Frontiers in Pharmacology. 2023;14:1252757. doi: 10.3389/fphar.2023.1252757.
   Google Scholar
• Simonsson C, Lövfors W, Bergqvist N, Nyman E, Gennemark P, Stenkula KG, et al. A multi-scale in silico mouse model for diet-induced insulin resistance. Biochemical Engineering Journal. 2023;191:108798. doi: 10.1016/j.bej.2022.108798.
   Google Scholar
• Ilyas IF, Chu X. Outlier detection. Data cleaning: Morgan & Claypool. 2019. doi: 10.1145/3310205.3310208.
   Google Scholar
• Belcher BT, Bower EH, Burford B, Celis MR, Fahimipour AK, Guevara IL, et al. Demystifying image-based machine learning: a practical guide to automated analysis of field imagery using modern machine learning tools. Frontiers in Marine Science. 2023;10:1157370. doi: 10.3389/fmars.2023.1157370.
   Google Scholar
• Börner K, Bueckle A, Ginda M. Data visualization literacy: Definitions, conceptual frameworks, exercises, and assessments. Proceedings of the National Academy of Sciences. 2019;116(6):1857-64. doi: 10.1073/pnas.1807180116.
   Google Scholar
• Draxl C, Scheffler M. The NOMAD laboratory: from data sharing to artificial intelligence. Journal of Physics: Materials. 2019;2(3):036001. doi: 10.1088/2515-7639/ab13bb.
   Google Scholar
• Bharadiya JP. A Comparative Study of Business Intelligence and Artificial Intelligence with Big Data Analytics. American Journal of Artificial Intelligence. 2023;7(1):24. doi: 10.11648/j.ajai.20230701.14.
   Google Scholar
• Shu X, Ye Y. Knowledge Discovery: Methods from data mining and machine learning. Social Science Research. 2023;110:102817. doi: 10.1016/j.ssresearch.2022.102817.
   Google Scholar
• Olubamwo OO. Fatty liver index and risk of incident cardiometabolic disease and mortality: Itä-Suomen yliopisto. 2023. doi: 10.1136/bmjopen-2018-026949.
   Google Scholar
• Makino M, Yoshimoto R, Ono M, Itoko T, Katsuki T, Koseki A, et al. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning. Scientific reports. 2019;9(1):11862. doi: 10.1038/s41598-019-48263-5.
   Google Scholar
• Li I, Pan J, Goldwasser J, Verma N, Wong WP, Nuzumlalı MY, et al. Neural natural language processing for unstructured data in electronic health records: A review. Computer Science Review. 2022;46:100511. doi: 10.1016/j.cosrev.2022.100511.
   Google Scholar
• Liu J, Wang C, Liu S. Utility of ChatGPT in clinical practice. Journal of Medical Internet Research. 2023;25:e48568. doi: 10.2196/48568.
   Google Scholar
• Lee S, Doktorchik C, Martin EA, D'Souza AG, Eastwood C, Shaheen AA, et al. Electronic medical record–based case phenotyping for the charlson conditions: Scoping review. JMIR medical informatics. 2021;9(2):e23934. doi: 10.2196/23934.
   Google Scholar
• Borna S, Maniaci MJ, Haider CR, Maita KC, Torres-Guzman RA, Avila FR, et al. Artificial Intelligence Models in Health Information Exchange: A Systematic Review of Clinical Implications. Healthcare; 2023; 2023. p. 2584. doi: 10.3390/healthcare11182584.
   Google Scholar
• Zheng L, Wang Y, Hao S, Shin AY, Jin B, Ngo AD, et al. Web-based real-time case finding for the population health management of patients with Diabetes Mellitus: A prospective validation of the natural language processing–based algorithm with statewide electronic medical records. JMIR medical informatics. 2016;4(4):e6328. doi: 10.2196/medinform.6328.
   Google Scholar
• Mollaei N, Cepeda C, Rodrigues J, Gamboa H. Biomedical Text Mining: Applicability of Machine Learning-based Natural Language Processing in Medical Database. Biosignals. 2022; 2022. p. 159-66. doi: 10.5220/0010819500003123.
   Google Scholar
• Mora S, Turrisi R, Chiarella L, Tassi L, Mai R, Nobili L, et al. NLP-based tools for localization of the Epileptogenic Zone in patients with drug-resistant focal epilepsy. bioRxiv. 2022;2022.11. 18.516120. doi: 10.1038/s41598-024-51846-6.
   Google Scholar
• Jussupow E, Spohrer K, Heinzl A, Gawlitza J. Augmenting medical diagnosis decisions? An investigation into physicians’ decision-making process with artificial intelligence. Information Systems Research. 2021;32(3):713-35. doi: 10.1287/isre.2020.0980.
   Google Scholar
• Pei X, Yao X, Yang Y, Zhang H, Xia M, Huang R, et al. Efficacy of artificial intelligence-based screening for diabetic retinopathy in type 2 diabetes mellitus patients. Diabetes Research and Clinical Practice. 2022;184:109190. doi: 10.1016/j.diabres.2022.109190.
   Google Scholar
• Huang X, Wang H, She C, Feng J, Liu X, Hu X, et al. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy. Frontiers in Endocrinology. 2022;13:946915. doi: 10.3389/fendo.2022.946915.
   Google Scholar
• Avvisato R, Forzano I, Varzideh F, Mone P, Santulli G. A machine learning model identifies a functional connectome signature that predicts blood pressure levels: imaging insights from a large population of 35 882 patients. Oxford University Press US. 2023;1458-60. doi: 10.1093/cvr/cvac116.
   Google Scholar
• Chaki J, Ganesh ST, Cidham S, Theertan SA. Machine learning and artificial intelligence based Diabetes Mellitus detection and self-management: A systematic review. Journal of King Saud University-Computer and Information Sciences. 2022;34(6):3204-25. doi: 10.1016/j.jksuci.2020.06.013.
   Google Scholar
• Yu G, Chen Z, Wu J, Tan Y. Medical decision support system for cancer treatment in precision medicine in developing countries. Expert Systems with Applications. 2021;186:115725. doi: 10.1016/j.eswa.2021.115725.
   Google Scholar
• Secinaro S, Calandra D, Secinaro A, Muthurangu V, Biancone P. The role of artificial intelligence in healthcare: a structured literature review. BMC medical informatics and decision making. 2021;21:1-23. doi: 10.1186/s12911-021-01488-9.
   Google Scholar
• King TC, Aggarwal N, Taddeo M, Floridi L. Artificial intelligence crime: An interdisciplinary analysis of foreseeable threats and solutions. Science and engineering ethics. 2020;26:89-120. doi: 10.1007/s11948-018-00081-0.
   Google Scholar
• Liu Y, Wang J, Tang S, Zhang J, Wan J. Integrating information entropy and latent Dirichlet allocation models for analysis of safety accidents in the construction industry. Buildings. 2023;13(7):1831. doi: 10.3390/buildings13071831.
   Google Scholar
• Chakraborty A, Venkatraman JV. Pharmacovigilance Through Phased Clinical Trials, Post-Marketing Surveillance and Ongoing Life Cycle Safety. The Quintessence of Basic and Clinical Research and Scientific Publishing: Springer. 2023;427-42. doi: 10.1007/978-981-99-1284-1_27.
   Google Scholar
• Selvaraj C, Chandra I, Singh SK. Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Molecular diversity. 2021:1-21. doi: 10.1007/s11030-021-10326-z.
   Google Scholar
• Ghobakhloo M, Asadi S, Iranmanesh M, Foroughi B, Mubarak MF, Yadegaridehkordi E. Intelligent automation implementation and corporate sustainability performance: The enabling role of corporate social responsibility strategy. Technology in Society. 2023;102301. doi: 10.1016/j.techsoc.2023.102301.
   Google Scholar
• Steimers A, Schneider M. Sources of risk of AI systems. International Journal of Environmental Research and Public Health. 2022;19(6):3641. doi: 10.1016/j.wem.2014.12.007.
   Google Scholar
• Aliman N-M, Kester L, Yampolskiy R. Transdisciplinary AI observatory—retrospective analyses and future-oriented contradistinctions. Philosophies 2021;6(1):6. doi: 10.3390/philosophies6010006.
   Google Scholar
• Oikonomou EK, Khera R. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovascular Diabetology. 2023;22(1):259. doi: 10.1186/s12933-023-01985-3.
   Google Scholar
• Gautier T, Ziegler LB, Gerber MS, Campos-Náñez E, Patek SD. Artificial intelligence and diabetes technology: A review. Metabolism. 2021;124:154872. doi: 10.1016/j.metabol.2021.154872.
   Google Scholar
• Gou W, Ling C-w, He Y, Jiang Z, Fu Y, Xu F, et al. Interpretable machine learning framework reveals robust gut microbiome features associated with type 2 diabetes. Diabetes Care. 2021;44(2):358-66. doi: 10.2337/dc20-1536.
   Google Scholar
• Hunt PA. QSAR using 2D descriptors and TRIPOS'SIMCA. Journal of computer-aided molecular design. 1999;13:453-67. doi: 10.1023/A:1008091001082.
   Google Scholar
• Shi W, Guo J, Bao T. QSAR tools for toxicity prediction in risk assessment—Comparative analysis. QSAR in Safety Evaluation and Risk Assessment: Elsevier. 2024;203-18. doi: 10.1016/B978-0-443-15339-6.00016-3.
   Google Scholar
• Al-Shar’i NA. The design of TOPK inhibitors using similarity search, molecular docking, and MD simulations. Journal of Biomolecular Structure and Dynamics. 2024;1-12. doi: 10.1080/07391102.2024.2319107.
   Google Scholar
• Ridings J, Barratt M, Cary R, Earnshaw C, Eggington C, Ellis M, et al. Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. Toxicology. 1996;106(1-3):267-79. doi: 10.1016/0300-483X(95)03190-Q.
   Google Scholar
• Klopman G, Sedykh A. An MCASE approach to the search of a cure for Parkinson's Disease. BmC pharmacology. 2002;2:1-11. doi: 10.1186/1471-2210-2-8.
   Google Scholar
• Patel P, Navneesh N, Kurmi B, Rangra NK, Gupta GD, Rawat R, et al. 1, 3, 5-Triazine Based Hydroxamic Acid Analogues as HDAC Inhibitors: Integrated Modelling by 3D QSAR, Hypogen Pharmacophore Based Virtual Screening and Molecular Dynamic Simulation Studies. 2023. doi: 10.21203/rs.3.rs-2892636/v1.
   Google Scholar
• Banerjee S, Baidya SK, Adhikari N, Jha T. 3D-QSAR Studies: CoMFA, CoMSIA, and Topomer CoMFA Methods. Modeling Inhibitors of Matrix Metalloproteinases: CRC Press. 2023;32-53. doi: 10.1201/9781003303282.
   Google Scholar
• Tran TTN, Tran TDT, Bui TTT. Integration of machine learning in 3D-QSAR CoMSIA models for the identification of lipid antioxidant peptides. RSC advances. 2023;13(48):33707-20. doi: 10.1039/D3RA06690H.
   Google Scholar
• Storchi L, Cruciani G, Cross S. DeepGRID: Deep Learning Using GRID Descriptors for BBB Prediction. Journal of Chemical Information and Modeling. 2023;63(17):5496-512. doi: 10.1021/acs.jcim.3c00768.
   Google Scholar
• Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Jama. 2006;295(17):2003-17. doi: 10.1001/jama.295.17.2003.
   Google Scholar
• Vijayalakshmi M, Suresh AJ, Vadivelan S, Kaviarasan L, Srinivasan R, Magesh M. Synthesis and pharmacological evaluation of selective MAO-A inhibitors using structure and pharmacophore-based drug design. Journal of Molecular Structure. 2024;1301:137302. doi: 10.1016/j.molstruc.2023.137302.
   Google Scholar
• Whitehead TM, Strickland J, Conduit GJ, Borrel A, Mucs D, Baskerville-Abraham I. Quantifying the Benefits of Imputation over QSAR Methods in Toxicology Data Modeling. Journal of Chemical Information and Modeling. 2023. doi: 10.1021/acs.jcim.3c01695.
   Google Scholar
• P Mazanetz M, J Marmon R, BT Reisser C, Morao I. Drug discovery applications for KNIME: an open source data mining platform. Current topics in medicinal chemistry. 2012;12(18):1965-79. doi: 10.2174/156802612804910331.
   Google Scholar
• Seo S, Lee JW. Applications of Big Data and AI-Driven Technologies in CADD (Computer-Aided Drug Design). Computational Drug Discovery and Design: Springer. 2023;295-305. doi: 10.1007/978-1-0716-3441-7_16.
   Google Scholar
• Cephe A, Koçhan N, Aksel EG, İpekten F, Yerlitaş Sİ, Zararsız GE, et al. Bioinformatics and biostatistics in precision medicine. Oncology: Genomics, Precision Medicine and Therapeutic Targets: Springer. 2023;189-235. doi: 10.1007/978-981-99-1529-3_8.
   Google Scholar
• Pandey D, Nandave M, Kumar A. Pharmacovigilance System in the USA. Pharmacovigilance Essentials: Advances, Challenges and Global Perspectives: Springer. 2024;183-97. doi: 10.1007/978-981-99-8949-2_9.
   Google Scholar
• Li M, You R, Su Y, Zhou H, Gong S. Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess. Frontiers in Pharmacology. 2023;14:1169327. doi: 10.3389/fphar.2023.1169327.
   Google Scholar
• Rayón-Ramírez G, Alvarado-López S, Camacho-Sandoval R, Loera MJ, Svarch AE, Alcocer-Varela J. Strengthening the Pharmacovigilance System in Mexico: Implementation of VigiFlow and VigiLyze, as ICSR and Signal Detection Management Systems. Pharmaceutical Medicine. 2023;37(6):425-37. doi: 10.1007/s40290-023-00490-y.
   Google Scholar
• Abbas H, Zeitoun A, Watfa M, Karam R. Implementation of a Pharmacovigilance System in a Resources-Limited Country in the Context of COVID-19: Lebanon’s Success Story. Therapeutic Innovation & Regulatory Science. 2023;57(2):178-85. doi: 10.1007/s43441-022-00460-7.
   Google Scholar
• Choo SM, Sartori D, Lee SC, Yang H-C, Syed-Abdul S. Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST. JMIR Medical Informatics. 2024;12(1):e49643. doi: 10.2196/49643.
   Google Scholar
• Murali K, Kaur S, Prakash A, Medhi B. Artificial intelligence in pharmacovigilance: practical utility. Medknow. 2019;373-76. doi: 10.4103/ijp.IJP_814_19.
   Google Scholar
• Pétervári M, Benczik B, Balogh OM, Petrovich B, Ágg B, Ferdinandy P. Network analysis for signal detection in spontaneous adverse event reporting database: application of network weighting Normalization to characterize cardiovascular drug safety. Drug Safety. 2022;45(11):1423-38. doi: 10.1007/s40264-022-01225-9.
   Google Scholar